Jefferies Group LLC - ACELRX PHARMACEUTICALS INC ownership

ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 85 filers reported holding ACELRX PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.25 and the average weighting 0.4%.

Quarter-by-quarter ownership
Jefferies Group LLC ownership history of ACELRX PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2019$166,000
-20.2%
47,800
-46.9%
0.00%
-50.0%
Q4 2018$208,000
+477.8%
90,100
+663.6%
0.00%
Q1 2016$36,000
-98.0%
11,800
-97.5%
0.00%
-100.0%
Q4 2015$1,810,000
+132.9%
470,197
+520.5%
0.01%
+42.9%
Q2 2014$777,000
-43.2%
75,781
-33.5%
0.01%
-46.2%
Q1 2014$1,369,000
-19.3%
113,977
-24.0%
0.01%
+18.2%
Q4 2013$1,697,000150,0000.01%
Other shareholders
ACELRX PHARMACEUTICALS INC shareholders Q4 2013
NameSharesValueWeighting ↓
Perceptive Advisors 5,995,760$16,129,0001.12%
Palo Alto Investors LP 1,425,439$3,834,0000.29%
Granahan Investment Management 1,438,736$3,870,0000.14%
WealthTrust Axiom LLC 130,000$349,0000.13%
SHEPHERD KAPLAN KROCHUK, LLC 127,846$344,0000.09%
NIPPON LIFE INSURANCE CO 17,192$2,247,0000.06%
Joel Isaacson & Co., LLC 80,660$217,0000.05%
Cornerstone Capital, Inc. 47,200$127,0000.03%
OXFORD ASSET MANAGEMENT LLP 153,769$414,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 281,650$758,0000.01%
View complete list of ACELRX PHARMACEUTICALS INC shareholders